Clinical Trial Update: Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating strategies to reduce panel reactive antibodies in sensitized patients awaiting kidney transplantation. The study has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Tampa General Hospital | Conditions: End Stage Renal Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-06-29